Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Frenck RW Jr, et al.〔N Engl J Med. 2021 Jul 15;385(3):239-250〕（査読済み）
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Dionne A, et al.〔JAMA Cardiol. 2021 Aug 10;e213471〕（査読済み）
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
Ali K, et al.〔N Engl J Med. 2021 Aug 11;NEJMoa2109522〕（査読済み）
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021
Olson SM, et al.〔MMWR Morb Mortal Wkly Rep. 2021 Oct 22;70(42):1483-1488〕（査読済み）
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents